FV
Publications
41
Views
20 888
Downloads
1 750
Supervised works
0
Items per page
1 - 41 of 41
Title Published in Access level OA Policy Year Views Downloads
Prevalence of functional (psychogenic) parkinsonism in two Swiss movement disorders clinics and review of the literatureJournal of the Neurological Sciences
accessLevelRestricted
2018 394 1
Stimulation cérébrale profonde et «révolution translationnelle» : le rôle central des cliniciensRevue médicale suisse
accessLevelRestricted
2015 421 0
Stimulation cérébrale profonde : passé, présent et avenirRevue médicale suisse
accessLevelRestricted
2015 419 1
Stimulation cérébrale profonde lors de maladie de Parkinson et autres troubles du mouvement : indications, résultats et complicationsRevue médicale suisse
accessLevelRestricted
2015 452 2
A novel approach to reducing number of sensing units for wearable gait analysis systemsIEEE transactions on biomedical engineering
accessLevelRestricted
2013 575 0
Non-dopaminergic drugs for motor symptomsParkinson's Disease
2013 373 0
Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2013 602 1
Résistances thérapeutiques dans les mouvements anormauxRevue médicale suisse
accessLevelRestricted
2012 478 0
VPS35 mutations in Parkinson diseaseAmerican journal of human genetics
accessLevelPublic
2011 662 698
Levodopa in the treatment of Parkinson's disease: an old drug still going strongClinical interventions in aging
accessLevelPublic
2010 990 1 046
Virus, lymphocyte et cerveau : une nouvelle problématique neurologiqueRevue médicale suisse
accessLevelRestricted
2009 391 0
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2009 570 0
Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effectParkinsonism & related disorders
accessLevelRestricted
2008 561 0
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5Neurology
accessLevelRestricted
2008 574 0
NeuropsychiatrieRevue médicale suisse
accessLevelRestricted
2008 472 0
Richtlinien für die Behandlung des idiopathischen ParkinsonsyndromsSchweizer Archiv für Neurologie und Psychiatrie
accessLevelRestricted
2008 512 0
Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulationParkinsonism & related disorders
accessLevelRestricted
2008 407 0
Neurologie du système nerveux périphériqueRevue médicale suisse
2007 416 0
Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring systemIEEE transactions on biomedical engineering
accessLevelRestricted
2007 552 0
Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's diseaseMovement disorders
accessLevelRestricted
2007 540 0
Ambulatory monitoring of physical activities in patients with Parkinson's diseaseIEEE transactions on biomedical engineering
accessLevelRestricted
2007 500 0
Revisiter les maladies neurodégénérativesRevue médicale suisse
2006 442 0
Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?Movement disorders
accessLevelRestricted
2006 586 0
Mécanismes pathogéniques des maladies neurodégénératives : l'exemple de la sclérose latérale amyotrophiqueRevue médicale suisse
2006 475 0
Dégénérescence, régénérescence : un espoir thérapeutique pour la maladie de ParkinsonRevue médicale suisse
2006 486 0
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulationArchives of neurology
accessLevelRestricted
2006 516 0
Traitement actuel de la maladie de Parkinson : difficultés et controversesRevue médicale suisse
2005 494 0
Unis pour le meilleur..Revue médicale suisse
2005 458 0
Suicide after successful deep brain stimulation for movement disordersNeurology
accessLevelRestricted
2004 549 0
Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 yearsNeurology
accessLevelRestricted
2004 526 0
L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reductionNeurology
accessLevelRestricted
2004 527 0
Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoringIEEE transactions on biomedical engineering
accessLevelRestricted
2004 456 0
How do parkinsonian signs return after discontinuation of subthalamic DBS?Neurology
accessLevelRestricted
2003 575 0
The effect of aging on postural stability: a cross sectional and longitudinal studyNeurophysiologie clinique
accessLevelRestricted
2003 488 0
An ambulatory system to quantify bradykinesia and tremor in Parkinson's diseaseITAB 2003: conference proceedings, 4th International IEEE EMBS Special Topic Conference on Information Technology Applications in Biomedicine, 24-26 April 2003, Birmingham, United Kingdom: new solutions for new challenges
2003 352 0
Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14Neurology
accessLevelRestricted
2002 528 0
Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patientsNeurology
accessLevelRestricted
2002 452 1
Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changesTransplant international
accessLevelRestricted
2002 599 0
Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosisGastroenterology
accessLevelRestricted
2000 548 0
Olanzapine-induced neuroleptic malignant syndromeArchives of general psychiatry
accessLevelRestricted
1999 518 0
Temporal parameters and patterns of the foot roll over during walking: normative data for healthy adultsGait & posture
accessLevelRestricted
1999 452 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack